• {%brandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%subBrandMenuItems%}
    • {%itemName%} {%arrowSpan%}
        {%productMenuItems%}
    • {%selfProduct%}
      • {%languages%}
    • This website is for Irish Healthcare Professionals only

      Initiation and titration with Duodopa®

      • Duodopa® is initially given as monotherapy, but other PD medicines can be taken concurrently1

      - Duodopa® replaces multiple oral doses and may reduce pill burden2,3

      • Single-use medicine cassettes, containing Duodopa®, are inserted into the pump on a daily basis1
      • Treatment is usually administered during the individual's awake period. If medically justified, Duodopa® may be administered for up to 24 hours1
      • Duodopa® dosage can be individually adjusted by titration to optimise outcomes1
      • Duodopa® delivery system is tailorable, allowing administration of extra bolus doses as required1

      1. Duodopa® Summary of Product Characteristics, available on www.medicines.ie.

      2. Fernandez HH, et al. Mov Disord 2015;30:500-9.

      3. Boyd JT, et al. Clin Park Relat Disord 2020;2:25-34.


      The only LCIG

       



      Safety and tolerability


       

      IE-DUOD-220035. Date of preparation: November 2022.